{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:47:06Z","timestamp":1787669226564,"version":"build-2736575974"},"reference-count":111,"publisher":"American Academy of Implant Dentistry","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>There is no agreement of data on the subject of implant failure and the development of osteonecrosis in patients receiving antiresorptive agents. The purpose of this systematic review is to evaluate whether dental implants placed in patients on antiresorptive medication have an increased failure rate and whether the implant placement or the implant existence are risk factors for developing medication-related osteonecrosis of the jaw (MRONJ). An electronic search was conducted in PubMed\/Medline, and all publications fulfilling the inclusion criteria were included. The search was completed by a hand research of the references cited in all electronic identified publications, resulting in 411 articles. Based on the inclusion criteria, 32 studies were included, with a total of 5221 patients, 12\u2009751 implants, 618 cases of implants loss, and 136 cases of MRONJ analyzed. Because of the small number of studies, most of which were characterized by a low level of quality, it cannot be established that the use of antiresorptive medication affects dental implant survival rates. The risk of MRONJ as an early or late complication is also not well established. Therefore, successful dental implant procedures in patients receiving antiresorptive medication might be possible, but more studies need to be carried out in the future to verify this topic. Apart from intravenous antiresorptive drugs, which remain an absolute contraindication, the use of antiresorptive medication is not a contraindication to dental implantology, but it must be accompanied by careful treatment planning, informing patients about possible complications, and essential long follow-up periods.<\/jats:p>","DOI":"10.1563\/aaid-joi-d-19-00088","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T12:33:05Z","timestamp":1594729985000},"page":"169-180","source":"Crossref","is-referenced-by-count":22,"title":["Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review"],"prefix":"10.1563","volume":"47","author":[{"given":"Ioannis","family":"Papadakis","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, National and Kapodistrian University of Athens, Athens, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Spanou","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, National and Kapodistrian University of Athens, Athens, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demos","family":"Kalyvas","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, National and Kapodistrian University of Athens, Athens, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"434","reference":[{"key":"i1548-1336-47-2-169-b01","series-title":"Bone","first-page":"2","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","unstructured":"Russell\n              RG.\n            \n          \n          Bisphosphonates: the first 40 years.\n\t\t\t\t\tBone.\n\t\t\t\t\t2011;\n\t\t\t\t\t49:\n\t\t\t\t\t2\u2013\n\t\t\t\t\t19."},{"key":"i1548-1336-47-2-169-b02","series-title":"Lancet","first-page":"899","article-title":"Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout)","volume":"2","author":"Russell","year":"1970","unstructured":"Russell\n              RG,\n            \n            \n              Bisaz\n              S,\n            \n            \n              Fleisch\n              H,\n            \n            et al.\n\t\t\t\t\t\n          Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).\n\t\t\t\t\tLancet.\n\t\t\t\t\t1970;\n\t\t\t\t\t2:\n\t\t\t\t\t899\u2013\n\t\t\t\t\t902."},{"key":"i1548-1336-47-2-169-b03","series-title":"Oral Oncol","first-page":"1049","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","unstructured":"Rupel\n              K,\n            \n            \n              Ottaviani\n              G,\n            \n            \n              Gobbo\n              M,\n            \n            et al.\n\t\t\t\t\t\n          A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ).\n\t\t\t\t\tOral Oncol.\n\t\t\t\t\t2014;\n\t\t\t\t\t50:\n\t\t\t\t\t1049\u2013\n\t\t\t\t\t1057."},{"key":"i1548-1336-47-2-169-b04","series-title":"Clin Ther","first-page":"1837","article-title":"The pathophysiology and treatment of osteoporosis","volume":"37","author":"Drake","year":"2015","unstructured":"Drake\n              MT,\n            \n            \n              Clarke\n              BL,\n            \n            \n              Lewiecki\n              EM.\n            \n          \n          The pathophysiology and treatment of osteoporosis.\n\t\t\t\t\tClin Ther.\n\t\t\t\t\t2015;\n\t\t\t\t\t37:\n\t\t\t\t\t1837\u2013\n\t\t\t\t\t1850."},{"key":"i1548-1336-47-2-169-b05","series-title":"J Oral Maxillofacial Surg","first-page":"1938","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","unstructured":"Ruggiero\n              SL,\n            \n            \n              Dodson\n              TB,\n            \n            \n              Fantasia\n              J,\n            \n            et al.\n\t\t\t\t\t\n          American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2014;\n\t\t\t\t\t72:\n\t\t\t\t\t1938\u2013\n\t\t\t\t\t1956."},{"key":"i1548-1336-47-2-169-b06","series-title":"Clin Geriatr Med","first-page":"395","article-title":"Bisphosphonate treatment of osteoporosis","volume":"19","author":"Watts","year":"2003","unstructured":"Watts\n              NB.\n            \n          \n          Bisphosphonate treatment of osteoporosis.\n\t\t\t\t\tClin Geriatr Med.\n\t\t\t\t\t2003;\n\t\t\t\t\t19:\n\t\t\t\t\t395\u2013\n\t\t\t\t\t414."},{"key":"i1548-1336-47-2-169-b07","series-title":"N Engl J Med","first-page":"558","article-title":"The management of Paget's disease of bone","volume":"336","author":"Delmas","year":"1997","unstructured":"Delmas\n              PD,\n            \n            \n              Meunier\n              PJ.\n            \n          \n          The management of Paget's disease of bone.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t1997;\n\t\t\t\t\t336:\n\t\t\t\t\t558\u2013\n\t\t\t\t\t566."},{"key":"i1548-1336-47-2-169-b08","series-title":"J Bone Miner Res","first-page":"977","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","unstructured":"Letocha\n              AD,\n            \n            \n              Cintas\n              HL,\n            \n            \n              Troendle\n              JF,\n            \n            et al.\n\t\t\t\t\t\n          Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.\n\t\t\t\t\tJ Bone Miner Res.\n\t\t\t\t\t2005;\n\t\t\t\t\t20:\n\t\t\t\t\t977\u2013\n\t\t\t\t\t986."},{"key":"i1548-1336-47-2-169-b09","series-title":"Calcified Tissue Res","first-page":"269","article-title":"The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals","volume":"11","author":"Jung","year":"1973","unstructured":"Jung\n              A,\n            \n            \n              Bisaz\n              S,\n            \n            \n              Fleisch\n              H.\n            \n          \n          The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals.\n\t\t\t\t\tCalcified Tissue Res.\n\t\t\t\t\t1973;\n\t\t\t\t\t11:\n\t\t\t\t\t269\u2013\n\t\t\t\t\t280."},{"key":"i1548-1336-47-2-169-b10","series-title":"J Clin Invest","first-page":"2692","article-title":"Bisphosphonates: mechanisms of action","volume":"97","author":"Rodan","year":"1996","unstructured":"Rodan\n              GA,\n            \n            \n              Fleisch\n              HA.\n            \n          \n          Bisphosphonates: mechanisms of action.\n\t\t\t\t\tJ Clin Invest.\n\t\t\t\t\t1996;\n\t\t\t\t\t97:\n\t\t\t\t\t2692\u2013\n\t\t\t\t\t2696."},{"key":"i1548-1336-47-2-169-b11","series-title":"Bone","first-page":"848","article-title":"Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells","volume":"42","author":"Coxon","year":"2008","unstructured":"Coxon\n              FP,\n            \n            \n              Thompson\n              K,\n            \n            \n              Roelofs\n              AJ,\n            \n            \n              Ebetino\n              FH,\n            \n            \n              Rogers\n              MJ.\n            \n          \n          Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.\n\t\t\t\t\tBone.\n\t\t\t\t\t2008;\n\t\t\t\t\t42:\n\t\t\t\t\t848\u2013\n\t\t\t\t\t860."},{"key":"i1548-1336-47-2-169-b12","series-title":"Clin Oral Invest","first-page":"271","article-title":"Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings","volume":"14","author":"Hoefert","year":"2010","unstructured":"Hoefert\n              S,\n            \n            \n              Schmitz\n              I,\n            \n            \n              Tannapfel\n              A,\n            \n            \n              Eufinger\n              H.\n            \n          \n          Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.\n\t\t\t\t\tClin Oral Invest.\n\t\t\t\t\t2010;\n\t\t\t\t\t14:\n\t\t\t\t\t271\u2013\n\t\t\t\t\t284."},{"key":"i1548-1336-47-2-169-b13","series-title":"Mayo Clin Proc","first-page":"1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","unstructured":"Drake\n              MT,\n            \n            \n              Clarke\n              BL,\n            \n            \n              Khosla\n              S.\n            \n          \n          Bisphosphonates: mechanism of action and role in clinical practice.\n\t\t\t\t\tMayo Clin Proc.\n\t\t\t\t\t2008;\n\t\t\t\t\t83:\n\t\t\t\t\t1032\u2013\n\t\t\t\t\t1045."},{"key":"i1548-1336-47-2-169-b14","series-title":"J Bone Miner Res","first-page":"868","article-title":"Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone","volume":"18","author":"Cremers","year":"2003","unstructured":"Cremers\n              SC,\n            \n            \n              Eekhoff\n              ME,\n            \n            \n              Den Hartigh\n              J,\n            \n            \n              Hamdy\n              NA,\n            \n            \n              Vermeij\n              P,\n            \n            \n              Papapoulos\n              SE.\n            \n          \n          Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone.\n\t\t\t\t\tJ Bone Miner Res.\n\t\t\t\t\t2003;\n\t\t\t\t\t18:\n\t\t\t\t\t868\u2013\n\t\t\t\t\t875."},{"key":"i1548-1336-47-2-169-b15","series-title":"J Bone Miner Res","first-page":"1700","article-title":"Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis","volume":"12","author":"Khan","year":"1997","unstructured":"Khan\n              SA,\n            \n            \n              Kanis\n              JA,\n            \n            \n              Vasikaran\n              S,\n            \n            et al.\n\t\t\t\t\t\n          Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.\n\t\t\t\t\tJ Bone Miner Res.\n\t\t\t\t\t1997;\n\t\t\t\t\t12:\n\t\t\t\t\t1700\u2013\n\t\t\t\t\t1707."},{"key":"i1548-1336-47-2-169-b16","series-title":"Endocr Rev","first-page":"333","article-title":"Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","unstructured":"Black\n              DM,\n            \n            \n              Abrahamsen\n              B,\n            \n            \n              Bouxsein\n              ML,\n            \n            \n              Einhorn\n              T,\n            \n            \n              Napoli\n              N.\n            \n          \n          Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management.\n\t\t\t\t\tEndocr Rev.\n\t\t\t\t\t2019;\n\t\t\t\t\t40:\n\t\t\t\t\t333\u2013\n\t\t\t\t\t368."},{"key":"i1548-1336-47-2-169-b17","series-title":"J Bone Miner Res","first-page":"1729","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis","volume":"28","author":"Gedmintas","year":"2013","unstructured":"Gedmintas\n              L,\n            \n            \n              Solomon\n              DH,\n            \n            \n              Kim\n              SC.\n            \n          \n          Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.\n\t\t\t\t\tJ Bone Miner Res.\n\t\t\t\t\t2013;\n\t\t\t\t\t28:\n\t\t\t\t\t1729\u2013\n\t\t\t\t\t1737."},{"key":"i1548-1336-47-2-169-b18","series-title":"Dig Dis Sci","first-page":"1792","article-title":"Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa","volume":"45","author":"Lichtenberger","year":"2000","unstructured":"Lichtenberger\n              LM,\n            \n            \n              Romero\n              JJ,\n            \n            \n              Gibson\n              GW,\n            \n            \n              Blank\n              MA.\n            \n          \n          Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa.\n\t\t\t\t\tDig Dis Sci.\n\t\t\t\t\t2000;\n\t\t\t\t\t45:\n\t\t\t\t\t1792\u2013\n\t\t\t\t\t1801."},{"key":"i1548-1336-47-2-169-b19","series-title":"Dig Dis Sci","first-page":"1009","article-title":"Comparative study of potential for bisphosphonates to damage gastric mucosa of rats","volume":"43","author":"Peter","year":"1998","unstructured":"Peter\n              CP,\n            \n            \n              Kindt\n              MV,\n            \n            \n              Majka\n              JA.\n            \n          \n          Comparative study of potential for bisphosphonates to damage gastric mucosa of rats.\n\t\t\t\t\tDig Dis Sci.\n\t\t\t\t\t1998;\n\t\t\t\t\t43:\n\t\t\t\t\t1009\u2013\n\t\t\t\t\t1015."},{"key":"i1548-1336-47-2-169-b20","series-title":"Intern Med","first-page":"1049","article-title":"Symptoms and upper gastrointestinal mucosal injury associated with bisphosphonate therapy","volume":"58","author":"Yamamoto","year":"2019","unstructured":"Yamamoto\n              K,\n            \n            \n              Kishino\n              M,\n            \n            \n              Nakamura\n              S,\n            \n            \n              Tokushige\n              K.\n            \n          \n          Symptoms and upper gastrointestinal mucosal injury associated with bisphosphonate therapy.\n\t\t\t\t\tIntern Med.\n\t\t\t\t\t2019;\n\t\t\t\t\t58:\n\t\t\t\t\t1049\u2013\n\t\t\t\t\t1056."},{"key":"i1548-1336-47-2-169-b21","series-title":"J Clin Endocrinol Metab","first-page":"2149","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","unstructured":"Bone\n              HG,\n            \n            \n              Bolognese\n              MA,\n            \n            \n              Yuen\n              CK,\n            \n            et al.\n\t\t\t\t\t\n          Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.\n\t\t\t\t\tJ Clin Endocrinol Metab.\n\t\t\t\t\t2008;\n\t\t\t\t\t93:\n\t\t\t\t\t2149\u2013\n\t\t\t\t\t2157."},{"key":"i1548-1336-47-2-169-b22","series-title":"Expert Opin Drug Saf","first-page":"205","article-title":"The role and efficacy of denosumab in the treatment of osteoporosis: an update","volume":"10","author":"Charopoulos","year":"2011","unstructured":"Charopoulos\n              I,\n            \n            \n              Orme\n              S,\n            \n            \n              Giannoudis\n              PV.\n            \n          \n          The role and efficacy of denosumab in the treatment of osteoporosis: an update.\n\t\t\t\t\tExpert Opin Drug Saf.\n\t\t\t\t\t2011;\n\t\t\t\t\t10:\n\t\t\t\t\t205\u2013\n\t\t\t\t\t217."},{"key":"i1548-1336-47-2-169-b23","series-title":"J Clin Densitometry","first-page":"325","article-title":"Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases","volume":"11","author":"Delmas","year":"2008","unstructured":"Delmas\n              PD.\n            \n          \n          Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases.\n\t\t\t\t\tJ Clin Densitometry.\n\t\t\t\t\t2008;\n\t\t\t\t\t11:\n\t\t\t\t\t325\u2013\n\t\t\t\t\t338."},{"key":"i1548-1336-47-2-169-b24","series-title":"N Engl J Med","first-page":"756","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","unstructured":"Cummings\n              SR,\n            \n            \n              San Martin\n              J,\n            \n            \n              McClung\n              MR,\n            \n            et al.\n\t\t\t\t\t\n          Denosumab for prevention of fractures in postmenopausal women with osteoporosis.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2009;\n\t\t\t\t\t361:\n\t\t\t\t\t756\u2013\n\t\t\t\t\t765."},{"key":"i1548-1336-47-2-169-b25","series-title":"J Clin Oncol","first-page":"5132","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","unstructured":"Stopeck\n              AT,\n            \n            \n              Lipton\n              A,\n            \n            \n              Body\n              JJ,\n            \n            et al.\n\t\t\t\t\t\n          Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2010;\n\t\t\t\t\t28:\n\t\t\t\t\t5132\u2013\n\t\t\t\t\t5139."},{"key":"i1548-1336-47-2-169-b26","series-title":"Int J Clin Pract","first-page":"1139","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","unstructured":"Hanley\n              DA,\n            \n            \n              Adachi\n              JD,\n            \n            \n              Bell\n              A,\n            \n            \n              Brown\n              V.\n            \n          \n          Denosumab: mechanism of action and clinical outcomes.\n\t\t\t\t\tInt J Clin Pract.\n\t\t\t\t\t2012;\n\t\t\t\t\t66:\n\t\t\t\t\t1139\u2013\n\t\t\t\t\t1146."},{"key":"i1548-1336-47-2-169-b27","series-title":"Ther Clin Risk Manage","first-page":"295","article-title":"Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab","volume":"8","author":"Anastasilakis","year":"2012","unstructured":"Anastasilakis\n              AD,\n            \n            \n              Toulis\n              KA,\n            \n            \n              Polyzos\n              SA,\n            \n            \n              Anastasilakis\n              CD,\n            \n            \n              Makras\n              P.\n            \n          \n          Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab.\n\t\t\t\t\tTher Clin Risk Manage.\n\t\t\t\t\t2012;\n\t\t\t\t\t8:\n\t\t\t\t\t295\u2013\n\t\t\t\t\t306."},{"key":"i1548-1336-47-2-169-b28","series-title":"Clin Cancer Res","first-page":"6690","article-title":"Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy","volume":"14","author":"Lipton","year":"2008","unstructured":"Lipton\n              A,\n            \n            \n              Steger\n              GG,\n            \n            \n              Figueroa\n              J,\n            \n            et al.\n\t\t\t\t\t\n          Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy.\n\t\t\t\t\tClin Cancer Res.\n\t\t\t\t\t2008;\n\t\t\t\t\t14:\n\t\t\t\t\t6690\u2013\n\t\t\t\t\t6696."},{"key":"i1548-1336-47-2-169-b29","series-title":"Dent Clin North Am","first-page":"369","article-title":"Antiresorptive drug-related osteonecrosis of the jaw","volume":"58","author":"Uyanne","year":"2014","unstructured":"Uyanne\n              J,\n            \n            \n              Calhoun\n              CC,\n            \n            \n              Le\n              AD.\n            \n          \n          Antiresorptive drug-related osteonecrosis of the jaw.\n\t\t\t\t\tDent Clin North Am.\n\t\t\t\t\t2014;\n\t\t\t\t\t58:\n\t\t\t\t\t369\u2013\n\t\t\t\t\t384."},{"key":"i1548-1336-47-2-169-b30","series-title":"Osteoporosis Int","first-page":"1929","article-title":"Multiple clinical vertebral fractures following denosumab discontinuation","volume":"27","author":"Anastasilakis","year":"2016","unstructured":"Anastasilakis\n              AD,\n            \n            \n              Makras\n              P.\n            \n          \n          Multiple clinical vertebral fractures following denosumab discontinuation.\n\t\t\t\t\tOsteoporosis Int.\n\t\t\t\t\t2016;\n\t\t\t\t\t27:\n\t\t\t\t\t1929\u2013\n\t\t\t\t\t1930."},{"key":"i1548-1336-47-2-169-b31","series-title":"Osteoporosis Int","first-page":"1923","article-title":"Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports","volume":"27","author":"Aubry-Rozier","year":"2016","unstructured":"Aubry-Rozier\n              B,\n            \n            \n              Gonzalez-Rodriguez\n              E,\n            \n            \n              Stoll\n              D,\n            \n            \n              Lamy\n              O.\n            \n          \n          Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.\n\t\t\t\t\tOsteoporosis Int.\n\t\t\t\t\t2016;\n\t\t\t\t\t27:\n\t\t\t\t\t1923\u2013\n\t\t\t\t\t1925."},{"key":"i1548-1336-47-2-169-b32","series-title":"J Clin Endocrinol Metab","first-page":"2112","article-title":"Response to letter: severe rebound-associated vertebral fractures after denosumab discontinuation","volume":"102","author":"Lamy","year":"2017","unstructured":"Lamy\n              O,\n            \n            \n              Gonzalez-Rodriguez\n              E,\n            \n            \n              Aubry-Rozier\n              B.\n            \n          \n          Response to letter: severe rebound-associated vertebral fractures after denosumab discontinuation.\n\t\t\t\t\tJ Clin Endocrinol Metab.\n\t\t\t\t\t2017;\n\t\t\t\t\t102:\n\t\t\t\t\t2112."},{"key":"i1548-1336-47-2-169-b33","series-title":"J Bone Miner Res","first-page":"1291","article-title":"Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases","volume":"32","author":"Anastasilakis","year":"2017","unstructured":"Anastasilakis\n              AD,\n            \n            \n              Polyzos\n              SA,\n            \n            \n              Makras\n              P,\n            \n            \n              Aubry-Rozier\n              B,\n            \n            \n              Kaouri\n              S,\n            \n            \n              Lamy\n              O.\n            \n          \n          Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases.\n\t\t\t\t\tJ Bone Miner Res.\n\t\t\t\t\t2017;\n\t\t\t\t\t32:\n\t\t\t\t\t1291\u2013\n\t\t\t\t\t1296."},{"key":"i1548-1336-47-2-169-b34","series-title":"Bone","first-page":"11","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","unstructured":"Tsourdi\n              E,\n            \n            \n              Langdahl\n              B,\n            \n            \n              Cohen-Solal\n              M,\n            \n            et al.\n\t\t\t\t\t\n          Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS.\n\t\t\t\t\tBone.\n\t\t\t\t\t2017;\n\t\t\t\t\t105:\n\t\t\t\t\t11\u2013\n\t\t\t\t\t17."},{"key":"i1548-1336-47-2-169-b35","series-title":"Prz Menopauzalny","first-page":"213","article-title":"Hormone replacement therapy and the prevention of postmenopausal osteoporosis","volume":"13","author":"Gambacciani","year":"2014","unstructured":"Gambacciani\n              M,\n            \n            \n              Levancini\n              M.\n            \n          \n          Hormone replacement therapy and the prevention of postmenopausal osteoporosis.\n\t\t\t\t\tPrz Menopauzalny.\n\t\t\t\t\t2014;\n\t\t\t\t\t13:\n\t\t\t\t\t213\u2013\n\t\t\t\t\t220."},{"key":"i1548-1336-47-2-169-b36","series-title":"JAMA","first-page":"2265","article-title":"Hormone therapy for primary prevention of chronic conditions in postmenopausal women","volume":"318","author":"Jin","year":"2017","unstructured":"Jin\n              J.\n            \n          \n          Hormone therapy for primary prevention of chronic conditions in postmenopausal women.\n\t\t\t\t\tJAMA.\n\t\t\t\t\t2017;\n\t\t\t\t\t318:\n\t\t\t\t\t2265."},{"key":"i1548-1336-47-2-169-b37","series-title":"JAMA","first-page":"1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","unstructured":"Anderson\n              GL,\n            \n            \n              Limacher\n              M,\n            \n            \n              Assaf\n              AR,\n            \n            et al.\n\t\t\t\t\t\n          Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.\n\t\t\t\t\tJAMA.\n\t\t\t\t\t2004;\n\t\t\t\t\t291:\n\t\t\t\t\t1701\u2013\n\t\t\t\t\t1712."},{"key":"i1548-1336-47-2-169-b38","series-title":"JAMA","first-page":"1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","unstructured":"Cauley\n              JA,\n            \n            \n              Robbins\n              J,\n            \n            \n              Chen\n              Z,\n            \n            et al.\n\t\t\t\t\t\n          Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.\n\t\t\t\t\tJAMA.\n\t\t\t\t\t2003;\n\t\t\t\t\t290:\n\t\t\t\t\t1729\u2013\n\t\t\t\t\t1738."},{"key":"i1548-1336-47-2-169-b39","series-title":"Ann Intern Med","first-page":"818","article-title":"Clinical Guidelines Committee of the American College of Physicians. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","unstructured":"Qaseem\n              A,\n            \n            \n              Forciea\n              MA,\n            \n            \n              McLean\n              RM,\n            \n            \n              Denberg\n              TD;\n            \n          \n          Clinical Guidelines Committee of the American College of Physicians. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians.\n\t\t\t\t\tAnn Intern Med.\n\t\t\t\t\t2017;\n\t\t\t\t\t166:\n\t\t\t\t\t818\u2013\n\t\t\t\t\t839."},{"key":"i1548-1336-47-2-169-b40","series-title":"Expert Opin Dug Safety","first-page":"921","article-title":"Selective estrogen receptor modulators in clinical practice: a safety overview","volume":"14","author":"Ellis","year":"2015","unstructured":"Ellis\n              AJ,\n            \n            \n              Hendrick\n              VM,\n            \n            \n              Williams\n              R,\n            \n            \n              Komm\n              BS.\n            \n          \n          Selective estrogen receptor modulators in clinical practice: a safety overview.\n\t\t\t\t\tExpert Opin Dug Safety.\n\t\t\t\t\t2015;\n\t\t\t\t\t14:\n\t\t\t\t\t921\u2013\n\t\t\t\t\t934."},{"key":"i1548-1336-47-2-169-b41","series-title":"J Endocrinol Invest","first-page":"13","article-title":"Treatment of post-menopausal osteoporosis: beyond bisphosphonates","volume":"38","author":"Ishtiaq","year":"2015","unstructured":"Ishtiaq\n              S,\n            \n            \n              Fogelman\n              I,\n            \n            \n              Hampson\n              G.\n            \n          \n          Treatment of post-menopausal osteoporosis: beyond bisphosphonates.\n\t\t\t\t\tJ Endocrinol Invest.\n\t\t\t\t\t2015;\n\t\t\t\t\t38:\n\t\t\t\t\t13\u2013\n\t\t\t\t\t29."},{"key":"i1548-1336-47-2-169-b42","series-title":"N Engl J Med","first-page":"459","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","unstructured":"Meunier\n              PJ,\n            \n            \n              Roux\n              C,\n            \n            \n              Seeman\n              E,\n            \n            et al.\n\t\t\t\t\t\n          The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2004;\n\t\t\t\t\t350:\n\t\t\t\t\t459\u2013\n\t\t\t\t\t468."},{"key":"i1548-1336-47-2-169-b43","series-title":"J Clin Endocrinol Metab","first-page":"2816","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","unstructured":"Reginster\n              JY,\n            \n            \n              Seeman\n              E,\n            \n            \n              De Vernejoul\n              MC,\n            \n            et al.\n\t\t\t\t\t\n          Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.\n\t\t\t\t\tJ Clin Endocrinol Metab.\n\t\t\t\t\t2005;\n\t\t\t\t\t90:\n\t\t\t\t\t2816\u2013\n\t\t\t\t\t2822."},{"key":"i1548-1336-47-2-169-b44","series-title":"Strontium ranelate","article-title":"PSUR assessment report","year":"2013","unstructured":"Euopean Medicines Agency.\n          PSUR assessment report.\n\t\t\t\t\tStrontium ranelate.\n\t\t\t\t\t2013.\n\t\t\t\t\thttps:\/\/www.ema.europa.eu\/documents\/variation-report\/protelos-h-c-560-psu-0031-epar-assessment-report-periodic-safety-update-report_en.pdf. Accessed December 8,2018."},{"key":"i1548-1336-47-2-169-b45","series-title":"Calcified Tissue Int","first-page":"478","article-title":"Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture","volume":"71","author":"Huusko","year":"2002","unstructured":"Huusko\n              TM,\n            \n            \n              Karppi\n              P,\n            \n            \n              Kautiainen\n              H,\n            \n            \n              Suominen\n              H,\n            \n            \n              Avikainen\n              V,\n            \n            \n              Sulkava\n              R.\n            \n          \n          Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture.\n\t\t\t\t\tCalcified Tissue Int.\n\t\t\t\t\t2002;\n\t\t\t\t\t71:\n\t\t\t\t\t478\u2013\n\t\t\t\t\t484."},{"key":"i1548-1336-47-2-169-b46","series-title":"J Oral Maxillofac Surg","first-page":"1115","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","unstructured":"Marx\n              RE.\n            \n          \n          Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.\n\t\t\t\t\tJ Oral Maxillofac Surg.\n\t\t\t\t\t2003;\n\t\t\t\t\t61:\n\t\t\t\t\t1115\u2013\n\t\t\t\t\t1117."},{"key":"i1548-1336-47-2-169-b47","series-title":"J Can Dent Assoc.","article-title":"Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw","author":"Troeltzsch","year":"2012","unstructured":"Troeltzsch\n              M,\n            \n            \n              Woodlock\n              T,\n            \n            \n              Kriegelstein\n              S,\n            \n            \n              Steiner\n              T,\n            \n            \n              Messlinger\n              K,\n            \n            \n              Troeltzsch\n              M.\n            \n          \n          Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw.\n\t\t\t\t\tJ Can Dent Assoc.2012;\n\t\t\t\t\t78:c85."},{"key":"i1548-1336-47-2-169-b48","series-title":"Lancet","first-page":"813","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","unstructured":"Fizazi\n              K,\n            \n            \n              Carducci\n              M,\n            \n            \n              Smith\n              M,\n            \n            et al.\n\t\t\t\t\t\n          Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.\n\t\t\t\t\tLancet.\n\t\t\t\t\t2011;\n\t\t\t\t\t377:\n\t\t\t\t\t813\u2013\n\t\t\t\t\t822."},{"key":"i1548-1336-47-2-169-b49","series-title":"Breast Cancer Res Treat","first-page":"181","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","unstructured":"Guarneri\n              V,\n            \n            \n              Miles\n              D,\n            \n            \n              Robert\n              N,\n            \n            et al.\n\t\t\t\t\t\n          Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.\n\t\t\t\t\tBreast Cancer Res Treat.\n\t\t\t\t\t2010;\n\t\t\t\t\t122:\n\t\t\t\t\t181\u2013\n\t\t\t\t\t188."},{"key":"i1548-1336-47-2-169-b50","series-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod","first-page":"463","article-title":"Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases","volume":"110","author":"Hoefert","year":"2010","unstructured":"Hoefert\n              S,\n            \n            \n              Eufinger\n              H.\n            \n          \n          Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.\n\t\t\t\t\tOral Surg Oral Med Oral Pathol Oral Radiol Endod.\n\t\t\t\t\t2010;\n\t\t\t\t\t110:\n\t\t\t\t\t463\u2013\n\t\t\t\t\t469."},{"key":"i1548-1336-47-2-169-b51","series-title":"Oral Oncol","first-page":"191","article-title":"Surgery-triggered and non surgery-triggered bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study","volume":"47","author":"Vescovi","year":"2011","unstructured":"Vescovi\n              P,\n            \n            \n              Campisi\n              G,\n            \n            \n              Fusco\n              V,\n            \n            et al.\n\t\t\t\t\t\n          Surgery-triggered and non surgery-triggered bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study.\n\t\t\t\t\tOral Oncol.\n\t\t\t\t\t2011;\n\t\t\t\t\t47:\n\t\t\t\t\t191\u2013\n\t\t\t\t\t194."},{"key":"i1548-1336-47-2-169-b52","series-title":"J Clin Oncol","first-page":"5356","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","unstructured":"Vahtsevanos\n              K,\n            \n            \n              Kyrgidis\n              A,\n            \n            \n              Verrou\n              E,\n            \n            et al.\n\t\t\t\t\t\n          Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2009;\n\t\t\t\t\t27:\n\t\t\t\t\t5356\u2013\n\t\t\t\t\t5362."},{"key":"i1548-1336-47-2-169-b53","series-title":"Ann Oncol","first-page":"1341","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","unstructured":"Saad\n              F,\n            \n            \n              Brown\n              JE,\n            \n            \n              Van Poznak\n              C,\n            \n            et al.\n\t\t\t\t\t\n          Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.\n\t\t\t\t\tAnn Oncol.\n\t\t\t\t\t2012;\n\t\t\t\t\t23:\n\t\t\t\t\t1341\u2013\n\t\t\t\t\t1347."},{"key":"i1548-1336-47-2-169-b54","series-title":"J Oral Maxillofac Surg","first-page":"415","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","unstructured":"Mavrokokki\n              T,\n            \n            \n              Cheng\n              A,\n            \n            \n              Stein\n              B,\n            \n            \n              Goss\n              A.\n            \n          \n          Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.\n\t\t\t\t\tJ Oral Maxillofac Surg.\n\t\t\t\t\t2007;\n\t\t\t\t\t65:\n\t\t\t\t\t415\u2013\n\t\t\t\t\t423."},{"key":"i1548-1336-47-2-169-b55","series-title":"J Clin Oncol","first-page":"5904","article-title":"Natural history of osteonecrosis of the jaw in patients with multiple myeloma","volume":"26","author":"Badros","year":"2008","unstructured":"Badros\n              A,\n            \n            \n              Terpos\n              E,\n            \n            \n              Katodritou\n              E,\n            \n            et al.\n\t\t\t\t\t\n          Natural history of osteonecrosis of the jaw in patients with multiple myeloma.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2008;\n\t\t\t\t\t26:\n\t\t\t\t\t5904\u2013\n\t\t\t\t\t5909."},{"key":"i1548-1336-47-2-169-b56","series-title":"J Oral Maxillofac Surg","first-page":"1937.e1931","article-title":"Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws","volume":"72","author":"Holzinger","year":"2014","unstructured":"Holzinger\n              D,\n            \n            \n              Seemann\n              R,\n            \n            \n              Matoni\n              N,\n            \n            \n              Ewers\n              R,\n            \n            \n              Millesi\n              W,\n            \n            \n              Wutzl\n              A.\n            \n          \n          Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.\n\t\t\t\t\tJ Oral Maxillofac Surg.\n\t\t\t\t\t2014;\n\t\t\t\t\t72:\n\t\t\t\t\t1937.e1931\u2013\n\t\t\t\t\t1938."},{"key":"i1548-1336-47-2-169-b57","series-title":"Br J Oral Maxillofacial Surg","first-page":"874","article-title":"Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series","volume":"51","author":"Lopez-Cedrun","year":"2013","unstructured":"Lopez-Cedrun\n              JL,\n            \n            \n              Sanroman\n              JF,\n            \n            \n              Garcia\n              A,\n            \n            et al.\n\t\t\t\t\t\n          Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.\n\t\t\t\t\tBr J Oral Maxillofacial Surg.\n\t\t\t\t\t2013;\n\t\t\t\t\t51:\n\t\t\t\t\t874\u2013\n\t\t\t\t\t879."},{"key":"i1548-1336-47-2-169-b58","series-title":"J Calif Dent Assoc","first-page":"39","article-title":"The prognosis for dental implants placed in patients taking oral bisphosphonates","volume":"37","author":"Kasai","year":"2009","unstructured":"Kasai\n              T,\n            \n            \n              Pogrel\n              MA,\n            \n            \n              Hossaini\n              M.\n            \n          \n          The prognosis for dental implants placed in patients taking oral bisphosphonates.\n\t\t\t\t\tJ Calif Dent Assoc.\n\t\t\t\t\t2009;\n\t\t\t\t\t37:\n\t\t\t\t\t39\u2013\n\t\t\t\t\t42."},{"key":"i1548-1336-47-2-169-b59","series-title":"Clin Implant Dent Relat Res","first-page":"175","article-title":"Implant placement in patients with oral bisphosphonate therapy: a case series","volume":"12","author":"Shabestari","year":"2010","unstructured":"Shabestari\n              GO,\n            \n            \n              Shayesteh\n              YS,\n            \n            \n              Khojasteh\n              A,\n            \n            et al.\n\t\t\t\t\t\n          Implant placement in patients with oral bisphosphonate therapy: a case series.\n\t\t\t\t\tClin Implant Dent Relat Res.\n\t\t\t\t\t2010;\n\t\t\t\t\t12:\n\t\t\t\t\t175\u2013\n\t\t\t\t\t180."},{"key":"i1548-1336-47-2-169-b60","series-title":"Clin Oral Implants Res","first-page":"943","article-title":"Dental implants treatment outcomes in patient under active therapy with alendronate: 3-year follow-up results of a multicenter prospective observational study","volume":"27","author":"Tallarico","year":"2016","unstructured":"Tallarico\n              M,\n            \n            \n              Canullo\n              L,\n            \n            \n              Xhanari\n              E,\n            \n            \n              Meloni\n              SM.\n            \n          \n          Dental implants treatment outcomes in patient under active therapy with alendronate: 3-year follow-up results of a multicenter prospective observational study.\n\t\t\t\t\tClin Oral Implants Res.\n\t\t\t\t\t2016;\n\t\t\t\t\t27:\n\t\t\t\t\t943\u2013\n\t\t\t\t\t949."},{"key":"i1548-1336-47-2-169-b61","series-title":"J Clin Periodontol","first-page":"408","article-title":"Association between oral bisphosphonate use and dental implant failure among middle-aged women","volume":"39","author":"Yip","year":"2012","unstructured":"Yip\n              JK,\n            \n            \n              Borrell\n              LN,\n            \n            \n              Cho\n              SC,\n            \n            \n              Francisco\n              H,\n            \n            \n              Tarnow\n              DP.\n            \n          \n          Association between oral bisphosphonate use and dental implant failure among middle-aged women.\n\t\t\t\t\tJ Clin Periodontol.\n\t\t\t\t\t2012;\n\t\t\t\t\t39:\n\t\t\t\t\t408\u2013\n\t\t\t\t\t414."},{"key":"i1548-1336-47-2-169-b62","series-title":"J Craniofac Surg","first-page":"697","article-title":"Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis?","volume":"27","author":"Giovannacci","year":"2016","unstructured":"Giovannacci\n              I,\n            \n            \n              Meleti\n              M,\n            \n            \n              Manfredi\n              M,\n            \n            et al.\n\t\t\t\t\t\n          Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis?\n          \n            J Craniofac Surg\n          .\n\t\t\t\t\t2016;\n\t\t\t\t\t27:\n\t\t\t\t\t697\u2013\n\t\t\t\t\t701."},{"key":"i1548-1336-47-2-169-b63","series-title":"Clin Oral Implants Res","first-page":"632","article-title":"Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment","volume":"25","author":"Kwon","year":"2014","unstructured":"Kwon\n              TG,\n            \n            \n              Lee\n              CO,\n            \n            \n              Park\n              JW,\n            \n            \n              Choi\n              SY,\n            \n            \n              Rijal\n              G,\n            \n            \n              Shin\n              HI.\n            \n          \n          Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.\n\t\t\t\t\tClin Oral Implants Res.\n\t\t\t\t\t2014;\n\t\t\t\t\t25:\n\t\t\t\t\t632\u2013\n\t\t\t\t\t640."},{"key":"i1548-1336-47-2-169-b64","series-title":"Int J Oral Maxillofac Surg","first-page":"220","article-title":"Previously successful dental implants can fail when patients commence anti-resorptive therapy: a case series","volume":"47","author":"Pogrel","year":"2018","unstructured":"Pogrel\n              MA,\n            \n            \n              Ruggiero\n              SL.\n            \n          \n          Previously successful dental implants can fail when patients commence anti-resorptive therapy: a case series.\n\t\t\t\t\tInt J Oral Maxillofac Surg.\n\t\t\t\t\t2018;\n\t\t\t\t\t47:\n\t\t\t\t\t220\u2013\n\t\t\t\t\t222."},{"key":"i1548-1336-47-2-169-b65","series-title":"J Craniomaxillofacial Surg","first-page":"1945","article-title":"Clinical features of peri-implant medication-related osteonecrosis of the jaw: is there an association to peri-implantitis?","volume":"44","author":"Troeltzsch","year":"2016","unstructured":"Troeltzsch\n              M,\n            \n            \n              Cagna\n              D,\n            \n            \n              Stahler\n              P,\n            \n            et al.\n\t\t\t\t\t\n          Clinical features of peri-implant medication-related osteonecrosis of the jaw: is there an association to peri-implantitis?\n          \n            J Craniomaxillofacial Surg\n          .\n\t\t\t\t\t2016;\n\t\t\t\t\t44:\n\t\t\t\t\t1945\u2013\n\t\t\t\t\t1951."},{"key":"i1548-1336-47-2-169-b66","series-title":"Clin Oral Invest","first-page":"167","article-title":"Osteopathology induced by bisphosphonates and dental implants: clinical observations","volume":"17","author":"Jacobsen","year":"2013","unstructured":"Jacobsen\n              C,\n            \n            \n              Metzler\n              P,\n            \n            \n              Rossle\n              M,\n            \n            \n              Obwegeser\n              J,\n            \n            \n              Zemann\n              W,\n            \n            \n              Gratz\n              KW.\n            \n          \n          Osteopathology induced by bisphosphonates and dental implants: clinical observations.\n\t\t\t\t\tClin Oral Invest.\n\t\t\t\t\t2013;\n\t\t\t\t\t17:\n\t\t\t\t\t167\u2013\n\t\t\t\t\t175."},{"issue":"(suppl 4)","key":"i1548-1336-47-2-169-b67","series-title":"Endocr Pract","first-page":"1","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016","volume":"22","author":"Camacho","year":"2016","unstructured":"Camacho\n              PM,\n            \n            \n              Petak\n              SM,\n            \n            \n              Binkley\n              N,\n            \n            et al.\n\t\t\t\t\t\n          American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016.\n\t\t\t\t\tEndocr Pract.\n\t\t\t\t\t2016;\n\t\t\t\t\t22(suppl 4):\n\t\t\t\t\t1\u2013\n\t\t\t\t\t42."},{"key":"i1548-1336-47-2-169-b68","series-title":"Drug Des Dev Ther","first-page":"435","article-title":"Osteoporosis: a current view of pharmacological prevention and treatment","volume":"7","author":"Das","year":"2013","unstructured":"Das\n              S,\n            \n            \n              Crockett\n              JC.\n            \n          \n          Osteoporosis: a current view of pharmacological prevention and treatment.\n\t\t\t\t\tDrug Des Dev Ther.\n\t\t\t\t\t2013;\n\t\t\t\t\t7:\n\t\t\t\t\t435\u2013\n\t\t\t\t\t448."},{"key":"i1548-1336-47-2-169-b69","series-title":"J Clin Endocrinol Metab","first-page":"1802","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","unstructured":"Watts\n              NB,\n            \n            \n              Adler\n              RA,\n            \n            \n              Bilezikian\n              JP,\n            \n            et al.\n\t\t\t\t\t\n          Osteoporosis in men: an Endocrine Society clinical practice guideline.\n\t\t\t\t\tJ Clin Endocrinol Metab.\n\t\t\t\t\t2012;\n\t\t\t\t\t97:\n\t\t\t\t\t1802\u2013\n\t\t\t\t\t1822."},{"key":"i1548-1336-47-2-169-b70","series-title":"Arthritis Care Res","first-page":"1095","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","unstructured":"Buckley\n              L,\n            \n            \n              Guyatt\n              G,\n            \n            \n              Fink\n              HA,\n            \n            et al.\n\t\t\t\t\t\n          2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis.\n\t\t\t\t\tArthritis Care Res.\n\t\t\t\t\t2017;\n\t\t\t\t\t69:\n\t\t\t\t\t1095\u2013\n\t\t\t\t\t1110."},{"key":"i1548-1336-47-2-169-b71","series-title":"Int J Immunopathol Pharmacol","first-page":"455","article-title":"Potential applications of biphosphonates in dental surgical implants","volume":"20","author":"Berardi","year":"2007","unstructured":"Berardi\n              D,\n            \n            \n              Carlesi\n              T,\n            \n            \n              Rossi\n              F,\n            \n            \n              Calderini\n              M,\n            \n            \n              Volpi\n              R,\n            \n            \n              Perfetti\n              G.\n            \n          \n          Potential applications of biphosphonates in dental surgical implants.\n\t\t\t\t\tInt J Immunopathol Pharmacol.\n\t\t\t\t\t2007;\n\t\t\t\t\t20:\n\t\t\t\t\t455\u2013\n\t\t\t\t\t465."},{"key":"i1548-1336-47-2-169-b72","series-title":"Med Oral Patol Oral Cir Bucal","first-page":"e512","article-title":"Do topical applications of bisphosphonates improve bone formation in oral implantology? A systematic review","volume":"22","author":"Lozano-Carrascal","year":"2017","unstructured":"Lozano-Carrascal\n              N,\n            \n            \n              Salomo-Coll\n              O,\n            \n            \n              Hernandez-Alfaro\n              F,\n            \n            \n              Gehrke\n              SA,\n            \n            \n              Gargallo-Albiol\n              J,\n            \n            \n              Calvo-Guirado\n              JL.\n            \n          \n          Do topical applications of bisphosphonates improve bone formation in oral implantology? A systematic review.\n\t\t\t\t\tMed Oral Patol Oral Cir Bucal.\n\t\t\t\t\t2017;\n\t\t\t\t\t22:\n\t\t\t\t\te512\u2013\n\t\t\t\t\te519."},{"key":"i1548-1336-47-2-169-b73","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2018","unstructured":"Wells\n              G,\n            \n            \n              Shea\n              B,\n            \n            \n              O'Connell\n              D,\n            \n            et al.\n\t\t\t\t\t\n          The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.\n\t\t\t\t\thttp:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed July 18,2018."},{"key":"i1548-1336-47-2-169-b74","series-title":"Int J Oral Maxillofacial Implants","first-page":"349","article-title":"Safety of oral bisphosphonates: controlled studies on alveolar bone","volume":"21","author":"Jeffcoat","year":"2006","unstructured":"Jeffcoat\n              MK.\n            \n          \n          Safety of oral bisphosphonates: controlled studies on alveolar bone.\n\t\t\t\t\tInt J Oral Maxillofacial Implants.\n\t\t\t\t\t2006;\n\t\t\t\t\t21:\n\t\t\t\t\t349\u2013\n\t\t\t\t\t353."},{"key":"i1548-1336-47-2-169-b75","series-title":"J Oral Implantol","first-page":"85","article-title":"Immediate loading in mandible full-arch: pilot study in patients with osteoporosis in bisphosphonate therapy","volume":"38","author":"Leonida","year":"2012","unstructured":"Leonida\n              A,\n            \n            \n              Vescovi\n              P,\n            \n            \n              Baldoni\n              M,\n            \n            \n              Rossi\n              G,\n            \n            \n              Lauritano\n              D.\n            \n          \n          Immediate loading in mandible full-arch: pilot study in patients with osteoporosis in bisphosphonate therapy.\n\t\t\t\t\tJ Oral Implantol.\n\t\t\t\t\t2012;\n\t\t\t\t\t38:\n\t\t\t\t\t85\u2013\n\t\t\t\t\t94."},{"key":"i1548-1336-47-2-169-b76","series-title":"J Oral Implantol","article-title":"Immediate implant placement in a patient with osteoporosis undergoing bisphosphonate therapy: 1-year preliminary prospective study","author":"Siebert","year":"2015","unstructured":"Siebert\n              T,\n            \n            \n              Jurkovic\n              R,\n            \n            \n              Statelova\n              D,\n            \n            \n              Strecha\n              J.\n            \n          \n          Immediate implant placement in a patient with osteoporosis undergoing bisphosphonate therapy: 1-year preliminary prospective study.\n\t\t\t\t\tJ Oral Implantol.\n\t\t\t\t\t2015;\n\t\t\t\t\t41(spec no):360\u2013365."},{"key":"i1548-1336-47-2-169-b77","series-title":"J Oral Maxillofacial Surg","first-page":"337","article-title":"The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series","volume":"68","author":"Goss","year":"2010","unstructured":"Goss\n              A,\n            \n            \n              Bartold\n              M,\n            \n            \n              Sambrook\n              P,\n            \n            \n              Hawker\n              P.\n            \n          \n          The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2010;\n\t\t\t\t\t68:\n\t\t\t\t\t337\u2013\n\t\t\t\t\t343."},{"key":"i1548-1336-47-2-169-b78","series-title":"Int J Periodontics Restorative Den","first-page":"9","article-title":"Extensive autogenous bone augmentation and implantation in patients under bisphosphonate treatment: a 15-case series","volume":"36","author":"Khoury","year":"2016","unstructured":"Khoury\n              F,\n            \n            \n              Hidajat\n              H.\n            \n          \n          Extensive autogenous bone augmentation and implantation in patients under bisphosphonate treatment: a 15-case series.\n\t\t\t\t\tInt J Periodontics Restorative Den.\n\t\t\t\t\t2016;\n\t\t\t\t\t36:\n\t\t\t\t\t9\u2013\n\t\t\t\t\t18."},{"key":"i1548-1336-47-2-169-b79","series-title":"J Oral Maxillofacial Surg","first-page":"790","article-title":"Bisphosphonate-related osteonecrosis of the jaw associated with dental implants","volume":"68","author":"Lazarovici","year":"2010","unstructured":"Lazarovici\n              TS,\n            \n            \n              Yahalom\n              R,\n            \n            \n              Taicher\n              S,\n            \n            \n              Schwartz-Arad\n              D,\n            \n            \n              Peleg\n              O,\n            \n            \n              Yarom\n              N.\n            \n          \n          Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2010;\n\t\t\t\t\t68:\n\t\t\t\t\t790\u2013\n\t\t\t\t\t796."},{"key":"i1548-1336-47-2-169-b80","series-title":"J Oral Maxillofacial Surg","first-page":"508","article-title":"Characteristics of implant failures in patients with a history of oral bisphosphonate therapy","volume":"68","author":"Martin","year":"2010","unstructured":"Martin\n              DC,\n            \n            \n              O'Ryan\n              FS,\n            \n            \n              Indresano\n              AT,\n            \n            et al.\n\t\t\t\t\t\n          Characteristics of implant failures in patients with a history of oral bisphosphonate therapy.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2010;\n\t\t\t\t\t68:\n\t\t\t\t\t508\u2013\n\t\t\t\t\t514."},{"key":"i1548-1336-47-2-169-b81","series-title":"Int J Oral Maxillofacial Surg","first-page":"220","article-title":"Previously successful dental implants can fail when patients commence anti-resorptive therapy: a case series","volume":"47","author":"Pogrel","year":"2018","unstructured":"Pogrel\n              MA,\n            \n            \n              Ruggiero\n              SL.\n            \n          \n          Previously successful dental implants can fail when patients commence anti-resorptive therapy: a case series.\n\t\t\t\t\tInt J Oral Maxillofacial Surg.\n\t\t\t\t\t2018;\n\t\t\t\t\t47:\n\t\t\t\t\t220\u2013\n\t\t\t\t\t222."},{"key":"i1548-1336-47-2-169-b82","series-title":"Clin Implant Dent Relat Res","first-page":"751","article-title":"Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates: a presentation of six consecutive cases","volume":"16","author":"Tam","year":"2014","unstructured":"Tam\n              Y,\n            \n            \n              Kar\n              K,\n            \n            \n              Nowzari\n              H,\n            \n            \n              Cha\n              HS,\n            \n            \n              Ahn\n              KM.\n            \n          \n          Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates: a presentation of six consecutive cases.\n\t\t\t\t\tClin Implant Dent Relat Res.\n\t\t\t\t\t2014;\n\t\t\t\t\t16:\n\t\t\t\t\t751\u2013\n\t\t\t\t\t761."},{"key":"i1548-1336-47-2-169-b83","series-title":"Implant Dent","first-page":"328","article-title":"Osteoporosis and bisphosphonate-related osteonecrosis in a dental school implant patient population","volume":"24","author":"Al-Sabbagh","year":"2015","unstructured":"Al-Sabbagh\n              M,\n            \n            \n              Robinson\n              FG,\n            \n            \n              Romanos\n              G,\n            \n            \n              Thomas\n              MV.\n            \n          \n          Osteoporosis and bisphosphonate-related osteonecrosis in a dental school implant patient population.\n\t\t\t\t\tImplant Dent.\n\t\t\t\t\t2015;\n\t\t\t\t\t24:\n\t\t\t\t\t328\u2013\n\t\t\t\t\t332."},{"key":"i1548-1336-47-2-169-b84","series-title":"J Oral Maxillofacial Surg","first-page":"1022","article-title":"Oral bisphosphonates and dental implants: a retrospective study","volume":"66","author":"Bell","year":"2008","unstructured":"Bell\n              BM,\n            \n            \n              Bell\n              RE.\n            \n          \n          Oral bisphosphonates and dental implants: a retrospective study.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2008;\n\t\t\t\t\t66:\n\t\t\t\t\t1022\u2013\n\t\t\t\t\t1024."},{"key":"i1548-1336-47-2-169-b85","series-title":"J Oral Maxillofacial Surg","first-page":"1623","article-title":"The immediate placement of dental implants into extraction sites with periapical lesions: a retrospective chart review","volume":"69","author":"Bell","year":"2011","unstructured":"Bell\n              CL,\n            \n            \n              Diehl\n              D,\n            \n            \n              Bell\n              BM,\n            \n            \n              Bell\n              RE.\n            \n          \n          The immediate placement of dental implants into extraction sites with periapical lesions: a retrospective chart review.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2011;\n\t\t\t\t\t69:\n\t\t\t\t\t1623\u2013\n\t\t\t\t\t1627."},{"key":"i1548-1336-47-2-169-b86","series-title":"Compend Contin Educ Dent","first-page":"E106","article-title":"Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study","volume":"32","author":"Famili","year":"2011","unstructured":"Famili\n              P,\n            \n            \n              Quigley\n              S,\n            \n            \n              Mosher\n              T.\n            \n          \n          Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.\n\t\t\t\t\tCompend Contin Educ Dent.\n\t\t\t\t\t2011;\n\t\t\t\t\t32:\n\t\t\t\t\tE106\u2013\n\t\t\t\t\tE109."},{"key":"i1548-1336-47-2-169-b87","series-title":"J Periodontol","first-page":"1664","article-title":"Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices","volume":"78","author":"Fugazzotto","year":"2007","unstructured":"Fugazzotto\n              PA,\n            \n            \n              Lightfoot\n              WS,\n            \n            \n              Jaffin\n              R,\n            \n            \n              Kumar\n              A.\n            \n          \n          Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.\n\t\t\t\t\tJ Periodontol.\n\t\t\t\t\t2007;\n\t\t\t\t\t78:\n\t\t\t\t\t1664\u2013\n\t\t\t\t\t1669."},{"key":"i1548-1336-47-2-169-b88","series-title":"J Oral Maxillofacial Surg","first-page":"223","article-title":"Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases","volume":"66","author":"Grant","year":"2008","unstructured":"Grant\n              BT,\n            \n            \n              Amenedo\n              C,\n            \n            \n              Freeman\n              K,\n            \n            \n              Kraut\n              RA.\n            \n          \n          Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2008;\n\t\t\t\t\t66:\n\t\t\t\t\t223\u2013\n\t\t\t\t\t230."},{"key":"i1548-1336-47-2-169-b89","series-title":"J Oral Maxillofacial Surg","first-page":"e1931","article-title":"Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws","volume":"72","author":"Holzinger","year":"2014","unstructured":"Holzinger\n              D,\n            \n            \n              Seemann\n              R,\n            \n            \n              Matoni\n              N,\n            \n            \n              Ewers\n              R,\n            \n            \n              Millesi\n              W,\n            \n            \n              Wutzl\n              A.\n            \n          \n          Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.\n\t\t\t\t\tJ Oral Maxillofacial Surg.\n\t\t\t\t\t2014;\n\t\t\t\t\t72:\n\t\t\t\t\te1931\u2013\n\t\t\t\t\te1938."},{"key":"i1548-1336-47-2-169-b90","series-title":"J Posthodont Res","first-page":"108","article-title":"Survival of dental implants in post-menopausal bisphosphonate users","volume":"54","author":"Koka","year":"2010","unstructured":"Koka\n              S,\n            \n            \n              Babu\n              NM,\n            \n            \n              Norell\n              A.\n            \n          \n          Survival of dental implants in post-menopausal bisphosphonate users.\n\t\t\t\t\tJ Posthodont Res.\n\t\t\t\t\t2010;\n\t\t\t\t\t54:\n\t\t\t\t\t108\u2013\n\t\t\t\t\t111."},{"key":"i1548-1336-47-2-169-b91","series-title":"Int J Oral Maxillofacial Implants","first-page":"1216","article-title":"Oral bisphosphonates: early endosseous dental implant success and crestal bone changes. A retrospective study","volume":"27","author":"Memon","year":"2012","unstructured":"Memon\n              S,\n            \n            \n              Weltman\n              RL,\n            \n            \n              Katancik\n              JA.\n            \n          \n          Oral bisphosphonates: early endosseous dental implant success and crestal bone changes. A retrospective study.\n\t\t\t\t\tInt J Oral Maxillofacial Implants.\n\t\t\t\t\t2012;\n\t\t\t\t\t27:\n\t\t\t\t\t1216\u2013\n\t\t\t\t\t1222."},{"key":"i1548-1336-47-2-169-b92","series-title":"J Contemp Dent Pract","first-page":"414","article-title":"Intricate assessment and evaluation of dental implants in patients on bisphosphonate therapy: a retrospective analysis","volume":"17","author":"Suvarna","year":"2016","unstructured":"Suvarna\n              S,\n            \n            \n              Dutt\n              P,\n            \n            \n              Misra\n              A,\n            \n            \n              Usmani\n              N,\n            \n            \n              Singh\n              A,\n            \n            \n              Suvarna\n              C.\n            \n          \n          Intricate assessment and evaluation of dental implants in patients on bisphosphonate therapy: a retrospective analysis.\n\t\t\t\t\tJ Contemp Dent Pract.\n\t\t\t\t\t2016;\n\t\t\t\t\t17:\n\t\t\t\t\t414\u2013\n\t\t\t\t\t417."},{"key":"i1548-1336-47-2-169-b93","series-title":"Int J Oral Maxillofacial Implants","first-page":"71","article-title":"A retrospective study of 1925 consecutively placed immediate implants from 1988 to 2004","volume":"21","author":"Wagenberg","year":"2006","unstructured":"Wagenberg\n              B,\n            \n            \n              Froum\n              SJ.\n            \n          \n          A retrospective study of 1925 consecutively placed immediate implants from 1988 to 2004.\n\t\t\t\t\tInt J Oral Maxillofacial Implants.\n\t\t\t\t\t2006;\n\t\t\t\t\t21:\n\t\t\t\t\t71\u2013\n\t\t\t\t\t80."},{"key":"i1548-1336-47-2-169-b94","series-title":"J Oral Implantol","first-page":"335","article-title":"Influence of bisphosphonates on alveolar bone loss around osseointegrated implants","volume":"37","author":"Zahid","year":"2011","unstructured":"Zahid\n              TM,\n            \n            \n              Wang\n              BY,\n            \n            \n              Cohen\n              RE.\n            \n          \n          Influence of bisphosphonates on alveolar bone loss around osseointegrated implants.\n\t\t\t\t\tJ Oral Implantol.\n\t\t\t\t\t2011;\n\t\t\t\t\t37:\n\t\t\t\t\t335\u2013\n\t\t\t\t\t346."},{"key":"i1548-1336-47-2-169-b95","series-title":"Int J Oral Maxillofacial Implants","first-page":"605","article-title":"Long-term bone stability assessment around 1,187 immediately placed implants with 1- to 22-year follow-up","volume":"28","author":"Wagenberg","year":"2013","unstructured":"Wagenberg\n              BD,\n            \n            \n              Froum\n              SJ,\n            \n            \n              Eckert\n              SE.\n            \n          \n          Long-term bone stability assessment around 1,187 immediately placed implants with 1- to 22-year follow-up.\n\t\t\t\t\tInt J Oral Maxillofacial Implants.\n\t\t\t\t\t2013;\n\t\t\t\t\t28:\n\t\t\t\t\t605\u2013\n\t\t\t\t\t612."},{"key":"i1548-1336-47-2-169-b96","series-title":"J Craniofacial Surg","first-page":"749","article-title":"Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy","volume":"26","author":"Mozzati","year":"2015","unstructured":"Mozzati\n              M,\n            \n            \n              Arata\n              V,\n            \n            \n              Giacomello\n              M,\n            \n            et al.\n\t\t\t\t\t\n          Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy.\n\t\t\t\t\tJ Craniofacial Surg.\n\t\t\t\t\t2015;\n\t\t\t\t\t26:\n\t\t\t\t\t749\u2013\n\t\t\t\t\t755."},{"key":"i1548-1336-47-2-169-b97","series-title":"Int J Oral Maxillofacial Implants","first-page":"e247","article-title":"A decade of bisphosphonate bone complications: what it has taught us about bone physiology","volume":"29","author":"Marx","year":"2014","unstructured":"Marx\n              RE.\n            \n          \n          A decade of bisphosphonate bone complications: what it has taught us about bone physiology.\n\t\t\t\t\tInt J Oral Maxillofacial Implants.\n\t\t\t\t\t2014;\n\t\t\t\t\t29:\n\t\t\t\t\te247\u2013\n\t\t\t\t\te258."},{"key":"i1548-1336-47-2-169-b98","series-title":"Int J Dent","first-page":"451923","article-title":"Dental implant supported restorations improve quality of life in osteoporotic women","volume":"2015","author":"DeBaz","year":"2015","unstructured":"DeBaz\n              C,\n            \n            \n              Hahn\n              J,\n            \n            \n              Lang\n              L,\n            \n            \n              Palomo\n              L.\n            \n          \n          Dental implant supported restorations improve quality of life in osteoporotic women.\n\t\t\t\t\tInt J Dent.\n\t\t\t\t\t2015;\n\t\t\t\t\t2015:\n\t\t\t\t\t451923."},{"key":"i1548-1336-47-2-169-b99","series-title":"Clin Oral Implants Res","first-page":"46","article-title":"Overdenture effectiveness study team C. The effect of mandibular 2-implant overdentures on oral health-related quality of life: an international multicentre study","volume":"25","author":"Awad","year":"2014","unstructured":"Awad\n              MA,\n            \n            \n              Rashid\n              F,\n            \n            \n              Feine\n              JS,\n            \n          \n          Overdenture effectiveness study team C. The effect of mandibular 2-implant overdentures on oral health-related quality of life: an international multicentre study.\n\t\t\t\t\tClin Oral Implants Res.\n\t\t\t\t\t2014;\n\t\t\t\t\t25:\n\t\t\t\t\t46\u2013\n\t\t\t\t\t51."},{"key":"i1548-1336-47-2-169-b100","series-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod","first-page":"e10","article-title":"Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study","volume":"106","author":"Carmagnola","year":"2008","unstructured":"Carmagnola\n              D,\n            \n            \n              Celestino\n              S,\n            \n            \n              Abati\n              S.\n            \n          \n          Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.\n\t\t\t\t\tOral Surg Oral Med Oral Pathol Oral Radiol Endod.\n\t\t\t\t\t2008;\n\t\t\t\t\t106:\n\t\t\t\t\te10\u2013\n\t\t\t\t\te15."},{"key":"i1548-1336-47-2-169-b101","series-title":"Int J Oral Maxillofacial Surg","first-page":"1404","article-title":"The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series","volume":"41","author":"Jabbour","year":"2012","unstructured":"Jabbour\n              Z,\n            \n            \n              El-Hakim\n              M,\n            \n            \n              Mesbah-Ardakani\n              P,\n            \n            \n              Henderson\n              JE,\n            \n            \n              Albuquerque\n              R\n              Jr.\n            \n          \n          The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series.\n\t\t\t\t\tInt J Oral Maxillofacial Surg.\n\t\t\t\t\t2012;\n\t\t\t\t\t41:\n\t\t\t\t\t1404\u2013\n\t\t\t\t\t1409."},{"key":"i1548-1336-47-2-169-b102","series-title":"J Contemp Dent Pact","first-page":"63","article-title":"Osteonecrosis of the jaws secondary to bisphosphonate therapy: a case series","volume":"9","author":"Kumar","year":"2008","unstructured":"Kumar\n              SK,\n            \n            \n              Meru\n              M,\n            \n            \n              Sedghizadeh\n              PP.\n            \n          \n          Osteonecrosis of the jaws secondary to bisphosphonate therapy: a case series.\n\t\t\t\t\tJ Contemp Dent Pact.\n\t\t\t\t\t2008;\n\t\t\t\t\t9:\n\t\t\t\t\t63\u2013\n\t\t\t\t\t69."},{"key":"i1548-1336-47-2-169-b103","series-title":"J Prosthodont Res","first-page":"3","article-title":"Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab","volume":"59","author":"Niibe","year":"2015","unstructured":"Niibe\n              K,\n            \n            \n              Ouchi\n              T,\n            \n            \n              Iwasaki\n              R,\n            \n            \n              Nakagawa\n              T,\n            \n            \n              Horie\n              N.\n            \n          \n          Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab.\n\t\t\t\t\tJ Prosthodont Res.\n\t\t\t\t\t2015;\n\t\t\t\t\t59:\n\t\t\t\t\t3\u2013\n\t\t\t\t\t5."},{"key":"i1548-1336-47-2-169-b104","series-title":"J Am Dent Assoc","first-page":"1243","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs","volume":"142","author":"Hellstein","year":"2011","unstructured":"Hellstein\n              JW,\n            \n            \n              Adler\n              RA,\n            \n            \n              Edwards\n              B,\n            \n            et al.\n\t\t\t\t\t\n          Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs.\n\t\t\t\t\tJ Am Dent Assoc.\n\t\t\t\t\t2011;\n\t\t\t\t\t142:\n\t\t\t\t\t1243\u2013\n\t\t\t\t\t1251."},{"key":"i1548-1336-47-2-169-b105","series-title":"Deutsches Arzteblatt Int","first-page":"63","article-title":"The prevention of medication-related osteonecrosis of the jaw","volume":"114","author":"Poxleitner","year":"2017","unstructured":"Poxleitner\n              P,\n            \n            \n              Engelhardt\n              M,\n            \n            \n              Schmelzeisen\n              R,\n            \n            \n              Voss\n              P.\n            \n          \n          The prevention of medication-related osteonecrosis of the jaw.\n\t\t\t\t\tDeutsches Arzteblatt Int.\n\t\t\t\t\t2017;\n\t\t\t\t\t114:\n\t\t\t\t\t63\u2013\n\t\t\t\t\t69."},{"key":"i1548-1336-47-2-169-b106","series-title":"Periodontol 2000","first-page":"52","article-title":"Clinical indications for the use of chemical adjuncts to plaque control: chlorhexidine formulations","volume":"15","author":"Addy","year":"1997","unstructured":"Addy\n              M,\n            \n            \n              Moran\n              JM.\n            \n          \n          Clinical indications for the use of chemical adjuncts to plaque control: chlorhexidine formulations.\n\t\t\t\t\tPeriodontol 2000.\n\t\t\t\t\t1997;\n\t\t\t\t\t15:\n\t\t\t\t\t52\u2013\n\t\t\t\t\t54."},{"key":"i1548-1336-47-2-169-b107","series-title":"Implant Dent","first-page":"74","article-title":"Effectiveness of different commercial chlorhexidine-based mouthwashes after periodontal and implant surgery: a systematic review","volume":"28","author":"Chye","year":"2019","unstructured":"Chye\n              RML,\n            \n            \n              Perrotti\n              V,\n            \n            \n              Piattelli\n              A,\n            \n            \n              Iaculli\n              F,\n            \n            \n              Quaranta\n              A.\n            \n          \n          Effectiveness of different commercial chlorhexidine-based mouthwashes after periodontal and implant surgery: a systematic review.\n\t\t\t\t\tImplant Dent.\n\t\t\t\t\t2019;\n\t\t\t\t\t28:\n\t\t\t\t\t74\u2013\n\t\t\t\t\t85."},{"key":"i1548-1336-47-2-169-b108","series-title":"Clin Oral Invest","first-page":"21","article-title":"Efficacy of chlorhexidine rinses after periodontal or implant surgery: a systematic review","volume":"23","author":"Solderer","year":"2019","unstructured":"Solderer\n              A,\n            \n            \n              Kaufmann\n              M,\n            \n            \n              Hofer\n              D,\n            \n            \n              Wiedemeier\n              D,\n            \n            \n              Attin\n              T,\n            \n            \n              Schmidlin\n              PR.\n            \n          \n          Efficacy of chlorhexidine rinses after periodontal or implant surgery: a systematic review.\n\t\t\t\t\tClin Oral Invest.\n\t\t\t\t\t2019;\n\t\t\t\t\t23:\n\t\t\t\t\t21\u2013\n\t\t\t\t\t32."},{"key":"i1548-1336-47-2-169-b109","series-title":"Leuk Lymphoma","first-page":"2156","article-title":"Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates","volume":"49","author":"Montefusco","year":"2008","unstructured":"Montefusco\n              V,\n            \n            \n              Gay\n              F,\n            \n            \n              Spina\n              F,\n            \n            et al.\n\t\t\t\t\t\n          Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates.\n\t\t\t\t\tLeuk Lymphoma.\n\t\t\t\t\t2008;\n\t\t\t\t\t49:\n\t\t\t\t\t2156\u2013\n\t\t\t\t\t2162."},{"key":"i1548-1336-47-2-169-b110","series-title":"Int J Oral Maxillofacial Surg","first-page":"68","article-title":"Do antibiotics decrease implant failure and postoperative infections? A systematic review and meta-analysis","volume":"43","author":"Ata-Ali","year":"2014","unstructured":"Ata-Ali\n              J,\n            \n            \n              Ata-Ali\n              F,\n            \n            \n              Ata-Ali\n              F.\n            \n          \n          Do antibiotics decrease implant failure and postoperative infections? A systematic review and meta-analysis.\n\t\t\t\t\tInt J Oral Maxillofacial Surg.\n\t\t\t\t\t2014;\n\t\t\t\t\t43:\n\t\t\t\t\t68\u2013\n\t\t\t\t\t74."},{"key":"i1548-1336-47-2-169-b111","series-title":"DZZ","first-page":"64","article-title":"Tooth implants during medical treatment with bone antiresorptive agents (including bisphosphonate) S3-Leitlinie","volume":"72","author":"Walter","year":"2017","unstructured":"Walter\n              C,\n            \n            \n              Groetz\n              K,\n            \n            \n              Al-Nawas\n              B,\n            \n            \n              Ha\u00dffeld\n              S,\n            \n            \n              Sader\n              R,\n            \n            \n              Ullner\n              M.\n            \n          \n          Tooth implants during medical treatment with bone antiresorptive agents (including bisphosphonate) S3-Leitlinie.\n\t\t\t\t\tDZZ.\n\t\t\t\t\t2017;\n\t\t\t\t\t72:\n\t\t\t\t\t64\u2013\n\t\t\t\t\t74."}],"container-title":["Journal of Oral Implantology"],"original-title":[],"link":[{"URL":"https:\/\/joi.kglmeridian.com\/view\/journals\/orim\/47\/2\/article-p169.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/joi\/article-pdf\/47\/2\/169\/2831489\/i1548-1336-47-2-169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/joi.kglmeridian.com\/downloadpdf\/journals\/orim\/47\/2\/article-p169.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/joi.kglmeridian.com\/downloadpdf\/journals\/orim\/47\/2\/article-p169.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:17:56Z","timestamp":1752193076000},"score":1,"resource":{"primary":{"URL":"https:\/\/joi.kglmeridian.com\/view\/journals\/orim\/47\/2\/article-p169.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":111,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1563\/aaid-joi-d-19-00088","relation":{},"ISSN":["1548-1336","0160-6972"],"issn-type":[{"value":"1548-1336","type":"electronic"},{"value":"0160-6972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}